National Foundation for Cancer Research Parent

We Make Cures Possible

aka Cancer Research America - NFCR | Rockville, MD | www.NFCR.org

Learn how to support this organization

GuideStar Charity Check

National Foundation for Cancer Research

EIN: 04-2531031

Contributions tax deductible
as of September 2024

IRS BMF 509(a)(1)
as of September 09, 2024

View summary

Charity Check report

Mission

The National Foundation for Cancer Research (NFCR) was founded in 1973 to support cancer research and public education relating to prevention, early diagnosis, better treatments and, ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Research for a Cure--cures for all types of cancer.

Notes from the nonprofit

NFCR celebrated its 50 Year Anniversary in 2023. In those 50 years, NFCR has been focused on funding high-risk high reward research to find cures to all cancers. During this time, the organization has evolved but one thing has consistently remained the same NFCRs motivation and unwavering commitment to fund impact-driven research, improve patient lives, educate the public about cancer, and ultimately find a cure. In 2023, NFCR introduced a new logo and tagline We Make Cures Possible. Through our unique approach to scientific research and discovery a collaborative and holistic view of cancer and research process NFCR funds scientists who are unrestricted in their work, where they have the freedom to discover in their quest to find breakthrough treatments and therapies, with one goal in mind to improve patient care, find cures, and save lives.

Ruling year info

2010

President and Chief Executive Officer

Dr. Sujuan Ba Ph.D.

Main address

5515 Security Lane Suite 1105

Rockville, MD 20852 USA

Show more contact info

EIN

04-2531031

Subject area info

Cancers

Science

Population served info

Adults

NTEE code info

Cancer (G30)

Cancer Research (H30)

Fund Raising and/or Fund Distribution (U12)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms

Show Forms 990

Communication

Blog

Affiliations

See related organizations info

Programs and results

Reports and documents

What we aim to solve

SOURCE: Self-reported by organization

Cancer is newly diagnosed in 1.7 million Americans per year and annually claims the lives of 600 thousand of the country's men, women and children. Although tremendous strides have been made in the scientific understanding of the disease and development of measures to counter it, so very much more progress is necessary in laboratories, clinics and hospitals in order to produce better treatments, earlier diagnoses, preventive measures and, ultimately, cures for this most dreaded of ailments.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Cancer Research

Grants to support Cancer Researchers in the areas of cutting-edge basic and translational scientific research

Population(s) Served

Adults

Cancer Prevention, Early Detection and Treatment Awareness

Educational and awareness-building materials provided at no cost to more than 20 million U.S. residents per year in the areas of cancer prevention, early detection and treatment

Population(s) Served

Adults

Where we work

Affiliations & memberships

Better Business Bureau Wise Giving Alliance - Organization 2016

Photos

Videos

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of death caused by cancer

Totals By Year

Population(s) Served

Related Program

Cancer Research

Type of Metric

Outcome - describing the effects on people or issues

Direction of Success

Decreasing

Context Notes

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

What is the organization aiming to accomplish?

NFCR research funding promotes and facilitates worldwide collaboration among scientists to accelerate the pace of discovery from laboratory bench to patient bedside. We support of laboratories and dozens of scientists over the past 50 years has helped make possible cancer treatments that are saving lives today. In addition, NFCR provides cancer information to more than 25 million U.S. households annually to raise public awareness about cancer prevention and early diagnosis.

What are the organization's key strategies for making this happen?

NFCR seeks to pool immediately deployable funding to provide support for both basic and translational cancer research in and with some of America's best laboratories and their leading directors and teams. Also, we aim to educate more than 25 million U.S. households per year on the steps they and their loved ones can take to reduce cancer risk and better understand the disease.

What are the organization's capabilities for doing this?

NFCR offers robust research grants to some of America's best cancer researchers, funding that is unavailable from many other more traditional sources, such as universities, government agencies or corporations. We also have cultivated a constituency base of over 25 million U.S. households to whom we offer succinct, digestible cancer research updates, as well as early diagnosis and preventive best practices. This is all performed in conjunction with a world-class Scientific Advisory Board and is aided by the platform afforded by our creation and annual presentation of one of the global cancer research communities' most prestigious awards: the Szent-Gyorgyi Prize for Progress in Cancer Research, named after NFCR's Nobel Prize winning co-founder, Albert Szent-Gyorgyi.

What have they accomplished so far and what's next?

NFCR has provided more than $410 million for cutting-edge cancer research. We have supported hundreds of scientists since our founding in 1973. And we won't be finished until there is a cure for all cancer types.

How we listen

SOURCE: Self-reported by organization

Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.

We shared information about our current feedback practices.

How is your organization using feedback from the people you serve?

To identify and remedy poor client service experiences, To identify bright spots and enhance positive service experiences, To make fundamental changes to our programs and/or operations, To inform the development of new programs/projects, To strengthen relationships with the people we serve, To understand people's needs and how we can help them achieve their goals
Which of the following feedback practices does your organization routinely carry out?

We collect feedback from the people we serve at least annually, We aim to collect feedback from as many people we serve as possible, We take steps to ensure people feel comfortable being honest with us, We look for patterns in feedback based on people’s interactions with us (e.g., site, frequency of service, etc.), We engage the people who provide feedback in looking for ways we can improve in response, We act on the feedback we receive, We share the feedback we received with the people we serve, We tell the people who gave us feedback how we acted on their feedback, We ask the people who gave us feedback how well they think we responded
What challenges does the organization face when collecting feedback?

It is difficult to get the people we serve to respond to requests for feedback, It is difficult to find the ongoing funding to support feedback collection, Staff find it hard to prioritize feedback collection and review due to lack of time

Financials

National Foundation for Cancer Research

Fiscal year: Jan 01 - Dec 31

Financial documents

Yes, financials were audited by an independent accountant.

Revenue vs. expenses: breakdown

SOURCE: IRS Form 990

NET GAIN/LOSS: in

Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022

SOURCE: IRS Form 990

2.16

Average of 3.36 over 10 years

Months of cash in 2022

SOURCE: IRS Form 990

2.8

Average of 2.2 over 10 years

Fringe rate in 2022

SOURCE: IRS Form 990

14%

Average of 16% over 10 years

Funding sources

Source: IRS Form 990

Assets & liabilities

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

Digitizing IRS form 990 data

National Foundation for Cancer Research

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: Download Data

Revenue
Contributions	$13,577,309
Government Grants	$0
Program Services	$0
Investments	($11,167)
Special Events	($37,506)
Sales	$0
Other	$501,961
Total Revenue	$14,030,597

Expenses
Program Services	$9,956,675
Administration	$804,142
Fundraising	$3,881,620
Total Expenses	$14,642,437
Net Gain/Loss	($611,840)

Functional expenses
Accounting Fees	$52,420
Advertising & Promotion	$866
Information Technology Expenses	$408,094
Insurance Expenses	$31,948
Interest Expenses	$0
Investment Management Fees	$37,935
Legal Fees	$61,809
Pension Plan Contributions	$126,554
Professional Fundraising Expenses	$160,738

Revenue
Contributions	$3,460,179
Government Grants	$0
Program Services	$0
Investments	$131,265
Special Events	($4,188)
Sales	$0
Other	$201,578
Total Revenue	$3,788,834

Expenses
Program Services	$2,490,417
Administration	$172,931
Fundraising	$1,053,136
Total Expenses	$3,716,484
Net Gain/Loss	$72,350

Functional expenses
Accounting Fees	$5,900
Advertising & Promotion	$301
Information Technology Expenses	$112,283
Insurance Expenses	$7,624
Interest Expenses	$0
Investment Management Fees	$11,938
Legal Fees	$16,482
Pension Plan Contributions	$50,104
Professional Fundraising Expenses	$90,158

Revenue
Contributions	$13,617,695
Government Grants	$0
Program Services	$0
Investments	$368,774
Special Events	($41,847)
Sales	$0
Other	$687,659
Total Revenue	$14,632,281

Expenses
Program Services	$10,245,984
Administration	$805,989
Fundraising	$3,828,186
Total Expenses	$14,880,159
Net Gain/Loss	($247,878)

Functional expenses
Accounting Fees	$41,145
Advertising & Promotion	$566
Information Technology Expenses	$410,091
Insurance Expenses	$31,478
Interest Expenses	$0
Investment Management Fees	$52,786
Legal Fees	$72,432
Pension Plan Contributions	$95,657
Professional Fundraising Expenses	$144,233

Revenue
Contributions	$13,239,730
Government Grants	$0
Program Services	$0
Investments	$449,250
Special Events	($51,153)
Sales	$0
Other	$543,877
Total Revenue	$14,181,704

Expenses
Program Services	$9,789,526
Administration	$880,404
Fundraising	$3,859,756
Total Expenses	$14,529,686
Net Gain/Loss	($347,982)

Functional expenses
Accounting Fees	$41,020
Advertising & Promotion	$965
Information Technology Expenses	$327,611
Insurance Expenses	$34,383
Interest Expenses	$0
Investment Management Fees	$52,601
Legal Fees	$69,187
Pension Plan Contributions	$231,959
Professional Fundraising Expenses	$49,062

Revenue
Contributions	$13,729,294
Government Grants	$0
Program Services	$0
Investments	$451,210
Special Events	$3,945
Sales	$0
Other	$353,237
Total Revenue	$14,537,686

Expenses
Program Services	$9,777,414
Administration	$993,798
Fundraising	$2,748,518
Total Expenses	$13,519,730
Net Gain/Loss	$1,017,956

Functional expenses
Accounting Fees	$44,835
Advertising & Promotion	$1,455
Information Technology Expenses	$543,935
Insurance Expenses	$33,859
Interest Expenses	$0
Investment Management Fees	$52,181
Legal Fees	$69,183
Pension Plan Contributions	$102,328
Professional Fundraising Expenses	$66,504

Revenue
Contributions	$12,996,075
Government Grants	$0
Program Services	$0
Investments	$369,846
Special Events	($12,928)
Sales	$0
Other	$340,937
Total Revenue	$13,693,930

Expenses
Program Services	$10,402,397
Administration	$783,068
Fundraising	$2,604,765
Total Expenses	$13,790,230
Net Gain/Loss	($96,300)

Functional expenses
Accounting Fees	$45,180
Advertising & Promotion	$50
Information Technology Expenses	$210,720
Insurance Expenses	$36,194
Interest Expenses	$0
Investment Management Fees	$52,977
Legal Fees	$63,983
Pension Plan Contributions	$69,610
Professional Fundraising Expenses	$19,459

Revenue
Contributions	$14,884,024
Government Grants	$0
Program Services	$0
Investments	$528,158
Special Events	($48,305)
Sales	$0
Other	$387,455
Total Revenue	$15,751,332

Expenses
Program Services	$11,164,314
Administration	$884,108
Fundraising	$2,756,333
Total Expenses	$14,804,755
Net Gain/Loss	$946,577

Functional expenses
Accounting Fees	$38,763
Advertising & Promotion	$19,293
Information Technology Expenses	$312,833
Insurance Expenses	$35,943
Interest Expenses	$0
Investment Management Fees	$57,802
Legal Fees	$92,787
Pension Plan Contributions	$101,573
Professional Fundraising Expenses	$28,366

Revenue
Contributions	$13,729,474
Government Grants	$0
Program Services	$0
Investments	$291,958
Special Events	($87,397)
Sales	$0
Other	$367,765
Total Revenue	$14,301,800

Expenses
Program Services	$9,664,835
Administration	$836,311
Fundraising	$2,654,129
Total Expenses	$13,155,275
Net Gain/Loss	$1,146,525

Functional expenses
Accounting Fees	$40,478
Advertising & Promotion	$21,520
Information Technology Expenses	$416,866
Insurance Expenses	$36,412
Interest Expenses	$0
Investment Management Fees	$57,829
Legal Fees	$89,222
Pension Plan Contributions	$110,904
Professional Fundraising Expenses	$45,138

Revenue
Contributions	$13,952,247
Government Grants	$0
Program Services	$0
Investments	$364,941
Special Events	($15,236)
Sales	$0
Other	$362,042
Total Revenue	$14,663,994

Expenses
Program Services	$9,808,937
Administration	$971,759
Fundraising	$2,385,337
Total Expenses	$13,166,033
Net Gain/Loss	$1,497,961

Functional expenses
Accounting Fees	$41,680
Advertising & Promotion	$3,432
Information Technology Expenses	$432,264
Insurance Expenses	$36,618
Interest Expenses	$0
Investment Management Fees	$59,747
Legal Fees	$96,272
Pension Plan Contributions	$105,600
Professional Fundraising Expenses	$45,692

Revenue
Contributions	$11,921,451
Government Grants	$0
Program Services	$0
Investments	$740,805
Special Events	($11,155)
Sales	$0
Other	$307,544
Total Revenue	$12,958,645

Expenses
Program Services	$9,662,444
Administration	$1,083,915
Fundraising	$2,686,041
Total Expenses	$13,432,400
Net Gain/Loss	($473,755)

Functional expenses
Accounting Fees	$41,110
Advertising & Promotion	$47,377
Information Technology Expenses	$434,414
Insurance Expenses	$36,361
Interest Expenses	$0
Investment Management Fees	$64,774
Legal Fees	$140,391
Pension Plan Contributions	$123,315
Professional Fundraising Expenses	$50,237

Revenue
Contributions	$12,714,798
Government Grants	$0
Program Services	$0
Investments	$724,768
Special Events	($25,344)
Sales	$0
Other	$282,673
Total Revenue	$13,696,895

Expenses
Program Services	$11,190,752
Administration	$1,248,919
Fundraising	$2,708,060
Total Expenses	$15,147,731
Net Gain/Loss	($1,450,836)

Functional expenses
Accounting Fees	$42,520
Advertising & Promotion	$129,253
Information Technology Expenses	$421,220
Insurance Expenses	$38,649
Interest Expenses	$0
Investment Management Fees	$65,816
Legal Fees	$134,004
Pension Plan Contributions	$109,055
Professional Fundraising Expenses	$51,649

Revenue
Contributions	$9,878,471
Government Grants	$0
Program Services	$0
Investments	$769,613
Special Events	($26,572)
Sales	$0
Other	$316,393
Total Revenue	$10,937,905

Expenses
Program Services	$11,154,411
Administration	$1,086,709
Fundraising	$2,291,254
Total Expenses	$14,532,374
Net Gain/Loss	($3,594,469)

Functional expenses
Accounting Fees	$50,987
Advertising & Promotion	$160,473
Information Technology Expenses	$423,251
Insurance Expenses	$36,819
Interest Expenses	$0
Investment Management Fees	$45,806
Legal Fees	$62,692
Pension Plan Contributions	$183,526
Professional Fundraising Expenses	$64,945

Revenue
Contributions	$10,980,906
Government Grants	$10,000
Program Services	$0
Investments	$271,161
Special Events	($7,973)
Sales	$0
Other	$211,196
Total Revenue	$11,465,290

Expenses
Program Services	$8,279,122
Administration	$807,378
Fundraising	$1,743,501
Total Expenses	$10,830,001
Net Gain/Loss	$635,289

Functional expenses
Accounting Fees	$51,280
Advertising & Promotion	$31,785
Information Technology Expenses	$450,394
Insurance Expenses	$30,425
Interest Expenses	$0
Investment Management Fees	$36,839
Legal Fees	$9,044
Pension Plan Contributions	$175,458
Professional Fundraising Expenses	$66,290

Revenue
Contributions	$8,644,496
Government Grants	$800,000
Program Services	$0
Investments	$464,445
Special Events	($57)
Sales	$0
Other	$172,369
Total Revenue	$10,081,253

Expenses
Program Services	$7,872,730
Administration	$787,133
Fundraising	$1,534,644
Total Expenses	$10,194,507
Net Gain/Loss	($113,254)

Functional expenses
Accounting Fees	$49,131
Advertising & Promotion	$30,583
Information Technology Expenses	$359,480
Insurance Expenses	$28,804
Interest Expenses	$0
Investment Management Fees	$55,984
Legal Fees	$31,122
Pension Plan Contributions	$110,857
Professional Fundraising Expenses	$31,140

Revenue
Contributions	$8,181,991
Government Grants	$0
Program Services	$0
Investments	$138,215
Special Events	($1,267)
Sales	$0
Other	$89,120
Total Revenue	$8,408,059

Expenses
Program Services	$6,139,332
Administration	$757,000
Fundraising	$1,588,576
Total Expenses	$8,484,908
Net Gain/Loss	($76,849)

Functional expenses
Accounting Fees	$53,172
Advertising & Promotion	$36,338
Information Technology Expenses	$368,135
Insurance Expenses	$26,934
Interest Expenses	$0
Investment Management Fees	$27,852
Legal Fees	$23,310
Pension Plan Contributions	$106,328
Professional Fundraising Expenses	$31,557

National Foundation for Cancer Research

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: Download Data

Assets	Oct 01, 2008	Sep 30, 2009	Change
Contributions	$13,577,309
Cash & Equivalents	$1,376,270	$1,272,204	($104,066)
Accounts Receivable	$275,635	$305,645	$30,010
Pledges & Grants Receivable	$548,500	$36,333	($512,167)
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$7,091,168	$7,218,450	$127,282
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$103,072	$84,440	($18,632)
Other	$1,780,704	$1,914,573	$133,869
Total Assets	$11,175,349	$10,831,645	($343,704)

Liabilities	Oct 01, 2008	Sep 30, 2009	Change
Accounts Payable	$2,140,727	$2,352,625	$211,898
Grants Payable	$550,000	$418,750	($131,250)
Deferred Revenue	$0	$0	$0
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$2,690,727	$2,771,375	$80,648

Fund balance	Oct 01, 2008	Sep 30, 2009	Change
Temporarily Restricted Net Assets	$1,345,709	$1,376,857	$31,148
Permanently Restricted Net Assets	$1,411,509	$1,059,030	-$352,479
Total Restricted Net Assets	$2,757,218	$2,435,887	($321,331)
Unrestricted Net Assets	$5,727,404	$5,624,383	($103,021)
Net Assets	$8,484,622	$8,060,270	($424,352)

Assets	Oct 01, 2009	Dec 31, 2009	Change
Contributions	$3,460,179
Cash & Equivalents	$1,272,204	$700,097	($572,107)
Accounts Receivable	$305,645	$330,113	$24,468
Pledges & Grants Receivable	$36,333	$16,333	($20,000)
Receivable, Other	$0	$0	$0
Inventories for Sale or Use	$0	$0	$0
Investment, Securities	$7,218,450	$7,162,491	($55,959)
Investment, Other	$0	$0	$0
Fixed Assets (LBE - Depreciation)	$84,440	$76,611	($7,829)
Other	$1,914,573	$1,876,102	($38,471)
Total Assets	$10,831,645	$10,161,747	($669,898)

Liabilities	Oct 01, 2009	Dec 31, 2009	Change
Accounts Payable	$2,352,625	$1,329,036	($1,023,589)
Grants Payable	$418,750	$400,000	($18,750)
Deferred Revenue	$0	$0	$0
Loans and Notes	$0	$0	$0
Tax-Exempt Bond Liabilities	$0	$0	$0
Other	$0	$0	$0
Total Liabilities	$2,771,375	$1,729,036	($1,042,339)

National Foundation for Cancer Research

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of National Foundation for Cancer Research’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Fiscal year: Jan 01 - Dec 31 View full report Download data

Business model indicators

Profitability	2018	2019	2020	2021	2022
Unrestricted surplus (deficit) before depreciation	-$2,131,020	-$3,045,519	$988,357	$234,768	-$915,937
As % of expenses	-14.1%	-21.0%	9.2%	2.3%	-10.8%
Unrestricted surplus (deficit) after depreciation	-$2,166,961	-$3,083,615	$950,608	$200,358	-$930,703
As % of expenses	-14.3%	-21.2%	8.8%	2.0%	-11.0%

Revenue composition
Total revenue (unrestricted & restricted)	$13,696,895	$10,937,905	$11,465,290	$10,081,253	$8,408,059
Total revenue, % change over prior year	5.7%	-20.1%	4.8%	-12.1%	-16.6%
Program services revenue	0.0%	0.0%	0.0%	0.0%	0.0%
Membership dues	0.0%	0.0%	0.0%	0.0%	0.0%
Investment income	2.1%	2.4%	1.8%	2.4%	2.4%
Government grants	0.0%	0.0%	0.1%	7.9%	0.0%
All other grants and contributions	92.6%	90.1%	95.7%	85.7%	97.3%
Other revenue	5.2%	7.5%	2.4%	3.9%	0.3%

Expense composition
Total expenses before depreciation	$15,111,790	$14,494,278	$10,792,252	$10,160,097	$8,470,142
Total expenses, % change over prior year	12.8%	-4.1%	-25.5%	-5.9%	-16.6%
Personnel	18.9%	19.9%	24.6%	20.6%	25.9%
Professional fees	3.6%	3.3%	3.7%	4.2%	5.3%
Occupancy	1.6%	1.6%	2.1%	2.3%	2.7%
Interest	0.0%	0.0%	0.0%	0.0%	0.0%
Pass-through	26.5%	42.9%	39.9%	42.3%	27.0%
All other expenses	49.4%	32.3%	29.8%	30.7%	39.1%

Full cost components (estimated)	2018	2019	2020	2021	2022
Total expenses (after depreciation)	$15,147,731	$14,532,374	$10,830,001	$10,194,507	$8,484,908
One month of savings	$1,259,316	$1,207,857	$899,354	$846,675	$705,845
Debt principal payment	$0	$0	$0	$200,000	$200,000
Fixed asset additions	$50,440	$0	$0	$0	$0
Total full costs (estimated)	$16,457,487	$15,740,231	$11,729,355	$11,241,182	$9,390,753

Capital structure indicators

Liquidity	2018	2019	2020	2021	2022
Months of cash	0.9	1.3	2.4	2.6	2.8
Months of cash and investments	6.8	4.9	8.8	9.2	9.7
Months of estimated liquid unrestricted net assets	5.6	3.3	5.5	6.1	6.0

Balance sheet composition	2018	2019	2020	2021	2022
Cash	$1,168,990	$1,531,154	$2,126,572	$2,211,197	$1,977,541
Investments	$7,371,171	$4,349,518	$5,791,973	$5,539,340	$4,895,234
Receivables	$106,247	$201,229	$70,919	$87,021	$58,323
Gross land, buildings, equipment (LBE)	$387,823	$387,822	$393,083	$218,655	$226,556
Accumulated depreciation (as a % of LBE)	64.5%	74.3%	82.9%	83.6%	87.2%
Liabilities (as a % of assets)	22.5%	28.7%	27.4%	24.0%	29.0%
Unrestricted net assets	$7,141,083	$4,057,468	$5,008,076	$5,208,434	$4,277,731
Temporarily restricted net assets	$1,213,987	N/A	N/A	N/A	N/A
Permanently restricted net assets	$1,941,507	N/A	N/A	N/A	N/A
Total restricted net assets	$3,155,494	$3,472,001	$3,913,406	$4,015,442	$3,329,851
Total net assets	$10,296,577	$7,529,469	$8,921,482	$9,223,876	$7,607,582

Key data checks

Key data checks	2018	2019	2020	2021	2022
Material data errors	No	No	No	No	No

Operations

The people, governance practices, and partners that make the organization tick.

Documents

Letter of Determination

Form 1023/1024 is not available for this organization

President and Chief Executive Officer

Dr. Sujuan Ba Ph.D.

LinkedIn profile

Dr. Ba is recognized as one of the “Top 300 Women Leaders in Global Health" by the Global Health Programme at the Graduate Institute of International and Development Studies. Under her leadership, NFCR has established a powerful network of research centers/laboratories in the US and around the world. One of the high-profile and significant research programs emerging from this collaborative approach was the ScreenSaver-LifeSaver Project. Dr. Ba established a partnership between NFCR, United Devices, Inc., Intel Corp., and Oxford University to launch a distributed computing technology-based application linking together more than 3 million PC users globally to create the world's largest supercomputer which sped up the drug screening process. This program enabled scientists to perform virtual screenings of 3.5 billion small molecules against 12 target proteins to identify new anti-cancer drug candidates. Dr. Ba has led the Tissue Bank Consortium in Asia to promote the best practices for biorepositories and biobanks. This project is proclaimed an exemplary international platform for private, public and government partnership for international collaboration to advance cancer research. Dr. Ba led the launch of Szent-Györgyi Prize for Progress in Cancer Research, now an internationally recognized prize for outstanding scientific achievement. Dr. Ba serves on the executive committee of the GBM-AGILE Trial, an initiative to improve the survival of GBM patients with a global force of over 150 neurosurgeons, neuro-oncologists, pathologists, imagers, basic and clinical neuro scientists. This is a model that aims to breakdown silos and build knowledge bases to ensure that precision medicine is available to patients worldwide.

Number of employees

Source: IRS Form 990

National Foundation for Cancer Research

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of officer and director compensation data for this organization

National Foundation for Cancer Research

Highest paid employees

SOURCE: IRS Form 990

Compensation

Other

Show data for fiscal year

Compensation data

Download up to 5 most recent years of highest paid employee data for this organization

National Foundation for Cancer Research

Board of directors
as of 09/11/2024

SOURCE: Self-reported by organization

Board of directors data

Download the most recent year of board of directors data for this organization

Board chair

Dr. Alfred Slanetz

Geneius Biotechnology Inc.

Term: 2023 - 2026

Judith Barhard

Councilor, Buchanan & Mitchell, PC

Karen Burke

Mt. Sinai Medical Center

Franklin Salisbury

CEO Emeritus - NFCR

Brian Leyland-Jones

AIM-HI Accelerator Fund

Alfred Slanetz

Geneius Biotechnology Inc.

Silas Deane

Tyler Technologies

Padmakumar Kailmal

Suven Life Sciences

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

Board orientation and education
Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
CEO oversight
Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
Ethics and transparency
Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
Board composition
Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
Board performance
Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes

Organizational demographics

SOURCE: Self-reported; last updated 9/11/2024

Candid has made improvements to the race and ethnicity options.

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity

Asian/Asian American

Gender identity

Female

Sexual orientation

Decline to state

Disability status

Person without a disability

Race & ethnicity

No data

Gender identity

Transgender Identity

Sexual orientation

No data

Disability

No data

Equity strategies

Last updated: 01/04/2024

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

Data

We review compensation data across the organization (and by staff levels) to identify disparities by race.
We disaggregate data to adjust programming goals to keep pace with changing needs of the communities we support.
We employ non-traditional ways of gathering feedback on programs and trainings, which may include interviews, roundtables, and external reviews with/by community stakeholders.
We have long-term strategic plans and measurable goals for creating a culture such that one’s race identity has no influence on how they fare within the organization.

Policies and processes

We have a promotion process that anticipates and mitigates implicit and explicit biases about people of color serving in leadership positions.
We seek individuals from various race backgrounds for board and executive director/CEO positions within our organization.
We have community representation at the board level, either on the board itself or through a community advisory board.
We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
We measure and then disaggregate job satisfaction and retention data by race, function, level, and/or team.
We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.

Contractors

Fiscal year ending

Professional fundraisers

Fiscal year ending

SOURCE: IRS Form 990 Schedule G

Solicitation activities

Gross receipts from fundraising

Retained by organization

Paid to fundraiser

Related organizations & associated domestic grants

Show data for fiscal year

Related organization	Primary activity	Subsection	PC status	Controlling entity?	512(b)(13) controlled entity?	Cash grants paid	Non-cash assistance	Reason
RESEARCH FOR A CURE 5515 SECURITY LANE SUITE 1105 ROCKVILLE, MD 20852 01-0744146	CANCER RSRCH	501(C)3	509(A)(3)	NFCR	Y	$0.00	$0.00
DARWIN FOUNDATION 5515 SECURITY LANE SUITE 1105 ROCKVILLE, MD 20852 37-1473821	CANCER RSRCH	501(C)3	509(A)(3)	NFCR	Y	$0.00	$0.00

Related organization	Primary activity	Subsection	PC status	Controlling entity?	512(b)(13) controlled entity?	Cash grants paid	Non-cash assistance	Reason
DARWIN FOUNDATION 5515 SECURITY LANE SUITE 1105 ROCKVILLE, MD 20852 37-1473821	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	Y	$0.00	$0.00
RESEARCH FOR A CURE 5515 SECURITY LANE SUITE 1105 ROCKVILLE, MD 20852 01-0744146	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	Y	$0.00	$0.00

Related organization	Primary activity	Subsection	PC status	Controlling entity?	512(b)(13) controlled entity?	Cash grants paid	Non-cash assistance	Reason
DARWIN FOUNDATION 4600 EAST-WEST HIGHWAY 525 BETHESDA, MD 20814 37-1473821	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	N	$0.00	$0.00
RESEARCH FOR A CURE 4600 EAST-WEST HIGHWAY 525 BETHESDA, MD 20814 01-0744146	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	N	$0.00	$0.00

Related organization	Primary activity	Subsection	PC status	Controlling entity?	512(b)(13) controlled entity?	Cash grants paid	Non-cash assistance
FUND FOR INHERITED DISEASE RESEARCH INC 4600 EAST-WEST HIGHWAY 525 BETHESDA, MD 20814 47-0852643	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	N	$0.00	$0.00
CONSORTIUM FOR CLINICAL DIAGNOSTICS 4600 EAST-WEST HIGHWAY 525 BETHESDA, MD 20814 37-1473821	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	N	$0.00	$0.00
RESEARCH FOR A CURE 4600 EAST-WEST HIGHWAY 525 BETHESDA, MD 20814 01-0744146	CANCER RESEAR	501(C)3	509(A)(3)	NFCR	N	$0.00	$0.00

Related organization	Primary activity	Subsection	PC status	Controlling entity?	512(b)(13) controlled entity?	Cash grants paid	Non-cash assistance
FUND FOR INHERITED DISEASE RESEARCH, INC. 4600 EAST-WEST HIGHWAY, NO. 525 BETHESDA, MD 20814 47-0852643	CANCER RESEARCH	501(C)3	170(B)(1)(A)(V1)	NATIONAL FOUNDATION FOR CANCER RESEARCH	N	$0.00	$0.00
ASIAN FUND FOR CANCER RESEARCH LIMITED 5/F DAH SING LIFE BUILDING, 99-105 DES VOEUX CENTRAL	CANCER RESEARCH			NATIONAL FOUNDATION FOR CANCER RESEARCH	N	$0.00	$0.00
CONSORTIUM FOR CLINICAL DIAGNOSTICS 4600 EAST-WEST HIGHWAY, NO. 525 BETHESDA, MD 20814 37-1473821	CANCER RESEARCH	501(C)3	509(A)(3)	NATIONAL FOUNDATION FOR CANCER RESEARCH	N	$0.00	$0.00
RESEARCH FOR A CURE 4600 EAST-WEST HIGHWAY, NO. 525 BETHESDA, MD 20814 01-0744146	CANCER RESEARCH	501(C)3	509(A)(3)	NATIONAL FOUNDATION FOR CANCER RESEARCH	N	$0.00	$0.00

Related organization	Primary activity	Subsection	PC status	Controlling entity?	512(b)(13) controlled entity?	Cash grants paid	Non-cash assistance	Reason
FUND FOR INHERITED DISEASE RESEARCH, INC. 4600 EAST-WEST HIGHWAY, NO. 525 BETHESDA, MD 20814 47-0852643	CANCER RESEARCH	501(C)(3)	170(B)(I)(A)(VI)	NATIONAL FOUNDATION FOR CANCER RESEARCH		$0.00	$0.00
ASIAN FUND FOR CANCER RESEARCH OF NFCR LIMITED 5/F DAH SING LIFE BUILDING, 99-105 DES VOEUX ROAD CENTRAL, HONG KONG	CANCER RESEARCH			NATIONAL FOUNDATION FOR CANCER RESEARCH		$0.00	$0.00

National Foundation for Cancer Research Parent

We Make Cures Possible

Mission

Is this your nonprofit?

Programs and results

Reports and documents

What we aim to solve

Our programs

Cancer Research

Cancer Prevention, Early Detection and Treatment Awareness

Where we work

Affiliations & memberships

Our results

Evaluation documents

Number of death caused by cancer

Totals By Year

Population(s) Served

Related Program

Type of Metric

Direction of Success

Context Notes

Goals & Strategy

Charting impact

What is the organization aiming to accomplish?

What are the organization's key strategies for making this happen?

What are the organization's capabilities for doing this?

What have they accomplished so far and what's next?

How we listen

Financials

Financial documents

Revenue vs. expenses: breakdown

Liquidity in 2022 info

2.16

Months of cash in 2022 info

2.8

Fringe rate in 2022 info

14%

Funding sources info

Assets & liabilities info

Financial data

Digitizing IRS form 990 data

National Foundation for Cancer Research

National Foundation for Cancer Research

National Foundation for Cancer Research

Business model indicators

Capital structure indicators

Key data checks

Operations

Documents

President and Chief Executive Officer

Dr. Sujuan Ba Ph.D.

Number of employees

National Foundation for Cancer Research

Compensation data

National Foundation for Cancer Research

Compensation data

National Foundation for Cancer Research

Board of directors data

Dr. Alfred Slanetz

Board leadership practices

Board orientation and education

CEO oversight

Ethics and transparency

Board composition

Board performance

Organizational demographics

Leadership

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

Disability

Equity strategies

Contractors

Professional fundraisers

Solicitation activities

Related organizations & associated domestic grants

Liquidity in 2022

Months of cash in 2022

Fringe rate in 2022

Funding sources

Assets & liabilities